In the prefrontal cortex of human subjects with depression, the coverage of vessels by the aquaporin 4 (AQP-4)-immunoreactive endfeet of astrocytes is significantly reduced, even if the extent of those feet is not changed when labeled for the cytoskeletal protein GFAP (Rajkowska et al., 2013). This evidence concerns the gene GFAP and depressive symptom measurement.